Adding ketamine to fentanyl fails to reduce pain in trauma
Medscape highlights UC-led research study
Medscape highlighted research led by the University of Cincinnati's Jason McMullan, MD, that found adding intranasal ketamine to fentanyl does not improve pain scores in patients with out-of-hospital trauma injuries.
The research was recently published in the Annals of Emergency Medicine.
The team conducted a randomized clinical trial of 192 patients requiring out-of-hospital pain medication for acute traumatic injuries. Participants received standard care treatment with fentanyl followed by a single intranasal dose of either 50 mg of ketamine or a placebo.
Researchers found there was no statistically significant difference between the ketamine and placebo groups, and pain over 3 hours of emergency department care did not differ at any point between the two groups.
"Although adding intranasal ketamine did not prove effective in any measured outcome, ketamine did not increase the risk of important adverse events. Importantly, we observed no difference in sedation after receiving ketamine and fentanyl, and no episodes of laryngospasm or emergence phenomenon occurred," the study authors wrote.
Featured photo at top of ketamine vial. Photo/Jennifer Fontan/iStock.
Related Stories
CCM welcomes new film and media scoring faculty member J.R. Paredes
May 20, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of J.R. Paredes as CCM's new Assistant Professor of Film and Media Scoring. His faculty appointment officially begins on Aug. 15, 2026. Paredes is a composer, music producer and audio post-production specialist whose work spans film, television and commercial music. His credits include original scores for feature films and series distributed on platforms such as Apple TV+ and Prime Video, as well as extensive work in sound design and mixing for film and media.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.